The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Open accessAbstract
Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of a neoplastic disease of CD4+ T cells, adult T-cell leukemia (ATL), and inflammatory diseases including HTLV-1 associated myelopathy/tropical spastic paraparesis, dermatitis, and inflammatory lung diseases. ATL cells, which constitutively express CD25, resemble CD25+CD4+ regulatory T cells (T(reg)). Approximately 60% of ATL cases indeed harbor leukemic cells that express FoxP3, a key transcription factor for T(reg) cells. HTLV-1 encodes an antisense transcript, HTLV-1 bZIP factor (HBZ), which is expressed in all ATL cases. In this study, we show that transgenic expression of HBZ in CD4+ T cells induced T-cell lymphomas and systemic inflammation in mice, resembling diseases observed in HTLV-1 infected individuals. In HBZ-transgenic mice, CD4+Foxp3+ T(reg) cells and effector/memory CD4+ T cells increased in vivo. As a mechanism of increased T(reg) cells, HBZ expression directly induced Foxp3 gene transcription in T cells. The increased CD4+Foxp3+ T(reg) cells in HBZ transgenic mice were functionally impaired while their proliferation was enhanced. HBZ could physically interact with Foxp3 and NFAT, thereby impairing the suppressive function of T(reg) cells. Thus, the expression of HBZ in CD4+ T cells is a key mechanism of HTLV-1-induced neoplastic and inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Transgenic expression of HBZ in CD4+ T cells increases Foxp3+ Treg cells with impaired suppressive function. (A and B) Mouse splenocytes were stained with the indicated antibodies, and analyzed by flow cytometry. Representative dot plots gated on the CD4+ population are shown. For these experiments, HBZ-Tg mice without any symptoms were used. Tables show the mean ± SD (n = 5 for A, n = 3 for B). (C) The absolute number of Foxp3+ or Foxp3− CD4+ T cells in HBZ-Tg and non-Tg mice. The results shown are the mean ± SD (n = 3). (D) Flow cytometric analysis for the Foxp3 expression in CD4 single positive thymocytes. Representative dot plots gated on the CD4 single positive population are shown from three independent analyses. (E) Flow cytometric analyses of CD4+ T cells for Treg related molecules. Numbers in dot plots indicate mean fluorescence intensity (MFI) of each molecule in the rectangular gates. (F) Suppressive activity of Treg cells from HBZ- or non-Tg mice on T-cell proliferation. Sorted Foxp3+ T cells were cultured with CD4+CD25− cells of non-Tg mice as responder cells for 72 h with ConA or soluble anti-CD3 antibody and x-irradiated antigen presenting cells (APCs), and [3H] thymidine incorporation during the last 6 hours was measured. Results are means ± SD for triplicate cultures. (G) In vivo BrdU incorporation in total CD4+, Foxp3+CD4+, or Foxp3−CD4+ T cells. The results shown are the mean ± SD (n = 3). (H) Sorted Foxp3+ cells were labeled with CFSE and cultured with anti-CD3 antibody and x-irradiated APCs. After 96 hours, the cells were stained with anti-Foxp3, and CFSE dilution was analyzed for Foxp3+ cells. *, P<0.01; **, P<0.001 by two-tailed Student t-test.](/paper-figures/fccf9a1b8ae1440f894b70901be1a4a5/htlv-1-bzip-factor-induces-t-cell-lymphoma-and-systemic-inflammation-in-vivo-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Transgenic expression of HBZ in CD4+ T cells induced leukaemia and lymphoma following a long latent period [145].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Regulatory T Cells and Immune Tolerance
Sakaguchi, S., Yamaguchi, T., Nomura, T., & Ono, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.009 · Cited by 5,485
Self-citationThe Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,090
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
Self-citationAn essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,860
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & de Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,812
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Self-citationHTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,381
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Cited by
Sorted by citations
Historical review of the causes of cancer
Blackadar, C. B. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.54 · Cited by 418
Aida, Y., Murakami, H., Takahashi, M., & Takeshima, S. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00328 · Cited by 231
Watanabe, T. (2017) · Blood · doi:10.1182/blood-2016-09-692574 · Cited by 190
Immunological homeostasis of the eye
Mochizuki, M., Sugita, S., & Kamoi, K. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.10.002 · Cited by 178
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma—A Tale of Two Proteins: Tax and HBZ
Giam, C., & Semmes, O. J. (2016) · Viruses · doi:10.3390/v8060161 · Cited by 171
Futsch, N., Mahieux, R., & Dutartre, H. (2017) · Viruses · doi:10.3390/v10010001 · Cited by 155
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator
Zhao, T., Satou, Y., Sugata, K., Miyazato, P., Green, P. L., Imamura, T., & Matsuoka, M. (2011) · Blood · doi:10.1182/blood-2010-12-326199 · Cited by 165
Self-citationHuman T Cell Leukemia Virus Type 1: Persistence and Pathogenesis
Bangham, C. R. M. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053222 · Cited by 152
Ruggero, K., Guffanti, A., Corradin, A., Sharma, V. K., De Bellis, G., Corti, G., Grassi, A., Zanovello, P., Bronte, V., Ciminale, V., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02823-13 · Cited by 139
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis
Ma, G., Yasunaga, J., & Matsuoka, M. (2016) · Retrovirology · doi:10.1186/s12977-016-0249-x · Cited by 150
Self-citationHTLV-1 modulates the frequency and phenotype of FoxP3+CD4+T cells in virus-infected individuals
Satou, Y., Utsunomiya, A., Tanabe, J., Nakagawa, M., Nosaka, K., & Matsuoka, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-46 · Cited by 121
Self-citationHTLV-1: Persistence and pathogenesis
Cook, L. B. M., Elemans, M., Rowan, A. G., & Asquith, B. (2012) · Virology · doi:10.1016/j.virol.2012.09.028 · Cited by 115
Rosewick, N., Durkin, K., Artesi, M., Marçais, A., Hahaut, V., Griebel, P. J., Arsic, N., Avettand-Fènoël, V., Burny, A., Charlier, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15264 · Cited by 108
HTLV-1 bZIP factor: the key viral gene for pathogenesis
Matsuoka, M., & Mesnard, J.-M. (2020) · Retrovirology · doi:10.1186/s12977-020-0511-0 · Cited by 113
Self-citationBillman, M. R., Rueda, D., & Bangham, C. R. M. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12469.1 · Cited by 102
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?
Bangham, C. R. M., & Ratner, L. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.09.004 · Cited by 106
Matsuoka, M., & Yasunaga, J. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.08.010 · Cited by 102
Self-citationMolecular mechanisms of HTLV-1 infection and pathogenesis
Yasunaga, J., & Matsuoka, M. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0937-1 · Cited by 97
Self-citationAdult T-Cell Leukemia/Lymphoma
Mehta–Shah, N., Ratner, L., & Horwitz, S. M. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.021907 · Cited by 93
HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival
Mitobe, Y., Yasunaga, J., Furuta, R., & Matsuoka, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0942 · Cited by 99
Self-citationThe Exceptional Oncogenicity of HTLV-1
Tagaya, Y., & Gallo, R. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01425 · Cited by 90
Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
Enose-Akahata, Y., Vellucci, A., & Jacobson, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02563 · Cited by 88
HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression
Yamamoto-Taguchi, N., Satou, Y., Miyazato, P., Ohshima, K., Nakagawa, M., Katagiri, K., Kinashi, T., & Matsuoka, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003630 · Cited by 92
Self-citationKatsuya, H., Islam, S., Tan, B. J. Y., Ito, J., Miyazato, P., Matsuo, M., Inada, Y., Iwase, S. C., Uchiyama, Y., Hata, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.016 · Cited by 92
Self-citationGenetic alterations in adult T‐cell leukemia/lymphoma
Kogure, Y., & Kataoka, K. (2017) · Cancer Science · doi:10.1111/cas.13303 · Cited by 91
40 years of the human T-cell leukemia virus: past, present, and future
Tagaya, Y., Matsuoka, M., & Gallo, R. C. (2019) · F1000Research · doi:10.12688/f1000research.17479.1 · Cited by 87
Self-citationHTLV-1 bZIP Factor HBZ Promotes Cell Proliferation and Genetic Instability by Activating OncomiRs
Vernin, C., Thénoz, M., Pinatel, C., Gessain, A., Gout, O., Delfau‐Larue, M., Nazaret, N., Legras‐Lachuer, C., Wattel, E., & Mortreux, F. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3564 · Cited by 98
Yasuma-Mitobe, K., Yasunaga, J., Takemoto, K., Sugata, K., Mitobe, Y., Takenouchi, N., Nakagawa, M., Suzuki, Y., & Matsuoka, M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005372 · Cited by 94
Self-citationRowan, A. G., Dillon, R. J., Witkover, A., Melamed, A., Demontis, M.-A., Gillet, N. A., Mun, L. J., Bangham, C. R. M., Cook, L. B., Fields, P. A., et al. (2020) · Blood · doi:10.1182/blood.2019002665 · Cited by 84
HBZ and its roles in HTLV-1 oncogenesis
Zhao, T., & Matsuoka, M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00247 · Cited by 87
Self-citationHTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation
Sugata, K., Yasunaga, J., Kinosada, H., Mitobe, Y., Furuta, R., Mahgoub, M., Onishi, C., Nakashima, K., Ohshima, K., & Matsuoka, M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0361 · Cited by 84
Self-citationHuman T-cell leukaemia virus type 1: parasitism and pathogenesis
Bangham, C. R. M., & Matsuoka, M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0272 · Cited by 83
Self-citationTanaka, A., Yasunaga, J., Takai, K., & Matsuoka, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0436 · Cited by 86
Self-citationMa, G., Yasunaga, J., Fan, J., Yanagawa, S.-I., & Matsuoka, M. (2012) · Oncogene · doi:10.1038/onc.2012.450 · Cited by 85
Self-citationProtective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor
Sugata, K., Yasunaga, J., Mitobe, Y., Miura, M., Miyazato, P., Kohara, M., & Matsuoka, M. (2015) · Blood · doi:10.1182/blood-2015-04-641118 · Cited by 79
Self-citationHTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines
Sugata, K., Satou, Y., Yasunaga, J., Hara, H., Ohshima, K., Utsunomiya, A., Mitsuyama, M., & Matsuoka, M. (2011) · Blood · doi:10.1182/blood-2011-05-357459 · Cited by 79
Self-citationTan, B. J. Y., Sugata, K., Reda, O., Matsuo, M., Uchiyama, K., Miyazato, P., Hahaut, V., Yamagishi, M., Uchimaru, K., Suzuki, Y., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150472 · Cited by 76
Self-citationViral causes of feline lymphoma: Retroviruses and beyond
Beatty, J. A. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.05.026 · Cited by 71
An animal model of adult T-cell leukemia: humanized mice with HTLV-1–specific immunity
Tezuka, K., Xun, R., Tei, M., Ueno, T., Tanaka, M., Takenouchi, N., & Fujisawa, J.-I. (2014) · Blood · doi:10.1182/blood-2013-06-508861 · Cited by 68
Human T-Cell Lymphotropic Virus: A Model of NF-κB-Associated Tumorigenesis
Qu, Z., & Xiao, G. (2011) · Viruses · doi:10.3390/v3060714 · Cited by 70
Hatano, Y., Ideta, T., Hirata, A., Hatano, K., Tomita, H., Okada, H., Shimizu, M., Tanaka, T., & Hara, A. (2021) · Cancers · doi:10.3390/cancers13112625 · Cited by 70
Human tumour viruses and the deregulation of cell polarity in cancer
Banks, L., Pim, D., & Thomas, M. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3400 · Cited by 69
Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
Pietropaolo, V., Prezioso, C., & Moens, U. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158346 · Cited by 65
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
Nishikawa, H., Maeda, Y., Ishida, T., Gnjatic, S., Sato, E., Mori, F., Sugiyama, D., Ito, A., Fukumori, Y., Utsunomiya, A., et al. (2012) · Blood · doi:10.1182/blood-2011-09-379982 · Cited by 64
Self-citationKinosada, H., Yasunaga, J., Shimura, K., Miyazato, P., Onishi, C., Iyoda, T., Inaba, K., & Matsuoka, M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006120 · Cited by 68
Self-citationMolecular Hallmarks of Adult T Cell Leukemia
Yamagishi, M., & Watanabe, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00334 · Cited by 63
Yamauchi, J., Araya, N., Yagishita, N., Sato, T., & Yamano, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107669 · Cited by 64
Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs)
Barbeau, B., & Mesnard, J.-M. (2011) · Viruses · doi:10.3390/v3050456 · Cited by 62
Araya, N., Sato, T., Yagishita, N., Ando, H., Utsunomiya, A., Jacobson, S., & Yamano, Y. (2011) · Viruses · doi:10.3390/v3091532 · Cited by 62
HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties
Ciminale, V., Rende, F., Bertazzoni, U., & Romanelli, M. G. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00398 · Cited by 61
Regulation of Human T-Lymphotropic Virus Type I Latency and Reactivation by HBZ and Rex
Philip, S., Zahoor, M. A., Zhi, H., Ho, Y.-K., & Giam, C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004040 · Cited by 65
ヒトT細胞白血病ウイルスは感染CD4T細胞に、過剰なT細胞活性化を誘導し成人T細胞白血病を引き起こす
Benjy, T. J. Y., & ベンジー, タ. ジ. ヤ. (2022) · Institutional Repositories DataBase (IRDB) · Cited by 59
The Role of HBZ in HTLV-1-Induced Oncogenesis
Zhao, T. (2016) · Viruses · doi:10.3390/v8020034 · Cited by 58
Self-citationOverview of biological mechanisms of human carcinogens
Birkett, N., Al‐Zoughool, M., Bird, M. G., Baan, R. A., Zielinski, J. M., & Krewski, D. R. (2019) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2019.1643539 · Cited by 55
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
Forlani, G., Shallak, M., Accolla, R. S., & Romanelli, M. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158001 · Cited by 53
HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
Yamagishi, M., Fujikawa, D., Watanabe, T., & Uchimaru, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01686 · Cited by 51
Higuchi, Y., Yasunaga, J., Mitagami, Y., Tsukamoto, H., Nakashima, K., Ohshima, K., & Matsuoka, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922884117 · Cited by 52
Self-citationViruses and Bacteria Associated with Cancer: An Overview
Zella, D., & Gallo, R. C. (2021) · Viruses · doi:10.3390/v13061039 · Cited by 53
Miura, M., Yasunaga, J., Tanabe, J., Sugata, K., Zhao, T., Ma, G., Miyazato, P., Ohshima, K., Kaneko, A., Watanabe, A., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-118 · Cited by 52
Self-citationHTLV-1 Rex: the courier of viral messages making use of the host vehicle
Nakano, K., & Watanabe, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00330 · Cited by 56
Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development
Yasunaga, J., & Matsuoka, M. (2017) · Cancer Science · doi:10.1111/cas.13443 · Cited by 47
Self-citationKamoi, K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00388 · Cited by 46
Kinosada, H., Yasunaga, J., Shimura, K., Miyazato, P., Onishi, C., Iyoda, T., Inaba, K., & Matsuoka, M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006228 · Cited by 46
Self-citationKamoi, K., & Mochizuki, M. (2012) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328358b9ec · Cited by 45
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
Enose‐Akahata, Y., Abrams, A., Massoud, R., Bialuk, I., Johnson, K. R., Green, P. L., Maloney, E. M., & Jacobson, S. (2013) · Retrovirology · doi:10.1186/1742-4690-10-19 · Cited by 49
Self-citationMolecular Determinants of Human T-lymphotropic Virus Type 1 Transmission and Spread
Lairmore, M. D., Anupam, R., Bowden, N., Haines, R., Haynes, R. A. H., Ratner, L., & Green, P. L. (2011) · Viruses · doi:10.3390/v3071131 · Cited by 49
Self-citationDetection of the HIV-1 Minus-Strand-Encoded Antisense Protein and Its Association with Autophagy
Torresilla, C., Larocque, É., Landry, S., Halin, M., Coulombe, Y., Masson, J., Mesnard, J.-M., & Barbeau, B. (2013) · Journal of Virology · doi:10.1128/jvi.00225-13 · Cited by 44
Nakamura, H., Shimizu, T., & Kawakami, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051459 · Cited by 44
Einsiedel, L., Chiong, F., Jersmann, H., & Taylor, G. P. (2021) · Retrovirology · doi:10.1186/s12977-020-00543-z · Cited by 43
Lavorgna, A., & Harhaj, E. W. (2014) · Viruses · doi:10.3390/v6103925 · Cited by 42
Saito, M., & Bangham, C. R. M. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/259045 · Cited by 42
Macaire, H., Riquet, A., Moncollin, V., Trescol-Biémont, M.-C., Dodon, M. D., Hermine, O., Mathieu, A., Mahieux, R., Mesnard, J.-M., Pierre, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.a112.340992 · Cited by 42
Animal models on HTLV-1 and related viruses: what did we learn?
Hajj, H. E., Nasr, R., Kfoury, Y. S., Dassouki, Z., Nasser, R., Kchour, G., Hermine, O., de Thé, H., & Bazarbachi, A. A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00333 · Cited by 46
Nozuma, S., Kubota, R., & Jacobson, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00881-w · Cited by 44
The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP
Wurm, T., Wright, D. G., Polakowski, N. J., Mesnard, J.-M., & Lemasson, I. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks244 · Cited by 44
Regulation of Latency in the Human T Cell Leukemia Virus, HTLV-1
Bangham, C. R. M., Miura, M., Kulkarni, A., & Matsuoka, M. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015501 · Cited by 45
Self-citationChevalier, S. A., Durand, S., Dasgupta, A., Radonovich, M. F., Cimarelli, A., Brady, J. N., Mahieux, R., & Pise-Masison, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041003 · Cited by 48
Identification and characterization of a novel enhancer in the HTLV-1 proviral genome
Matsuo, M., Ueno, T., Monde, K., Sugata, K., Tan, B. J. Y., Rahman, A., Miyazato, P., Uchiyama, K., Islam, S., Katsuya, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30029-9 · Cited by 42
Self-citationYin, H., Kannian, P., Dissinger, N. J., Haines, R., Niewiesk, S., & Green, P. L. (2012) · Journal of Virology · doi:10.1128/jvi.00717-12 · Cited by 43
Self-citationKawatsuki, A., Yasunaga, J., Mitobe, Y., Green, P. L., & Matsuoka, M. (2016) · Oncogene · doi:10.1038/onc.2015.510 · Cited by 45
Self-citationRaval, G., Bidoia, C., Forlani, G., Tosi, G., Gessain, A., & Accolla, R. S. (2015) · Retrovirology · doi:10.1186/s12977-015-0186-0 · Cited by 41
Mesnard, J.-M., Barbeau, B., Césaire, R., & Péloponèse, J. (2015) · Viruses · doi:10.3390/v7122952 · Cited by 42
Panfil, A. R., Dissinger, N. J., Howard, C. M., Murphy, B. M., Landes, K., Fernandez, S. A., & Green, P. L. (2016) · Journal of Virology · doi:10.1128/jvi.03113-15 · Cited by 39
Self-citationRegulation of HTLV-1 transformation
Ernzen, K. J., & Panfil, A. R. (2022) · Bioscience Reports · doi:10.1042/bsr20211921 · Cited by 39
Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis
Barbeau, B., Péloponèse, J., & Mesnard, J.-M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00226 · Cited by 40
The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
Vandermeulen, C., O’Grady, T. M., Wayet, J., Galvan, B., Maseko, S. B., Cherkaoui, M., Desbuleux, A., Coppin, G., Olivet, J., Ameur, L. B., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009919 · Cited by 37
Human T Cell Leukemia Virus Type 1 and Eye Diseases
Terada, Y., Kamoi, K., Komizo, T., Miyata, K., & Mochizuki, M. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0124 · Cited by 37
Mitagami, Y., Yasunaga, J., Kinosada, H., Ohshima, K., & Matsuoka, M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005120 · Cited by 42
Self-citationHTLV-2 APH-2 Expression Is Correlated With Proviral Load but APH-2 Does Not Promote Lymphocytosis
Douceron, E., Kaidarova, Z., Miyazato, P., Matsuoka, M., Murphy, E. L., & Mahieux, R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir708 · Cited by 36
Self-citationNasr, R., Hajj, H. E., Kfoury, Y. S., de Thé, H., Hermine, O., & Bazarbachi, A. A. (2011) · Viruses · doi:10.3390/v3060750 · Cited by 35
HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
Baratella, M., Forlani, G., & Accolla, R. S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02615 · Cited by 36
HTLV-1 Alters T Cells for Viral Persistence and Transmission
Tanaka, A., & Matsuoka, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00461 · Cited by 34
Self-citationTarokhian, H., Rahimi, H., Mosavat, A., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Bari, A., Ramezani, S., & Rezaee, S. A. (2018) · BMC Cancer · doi:10.1186/s12885-018-5209-5 · Cited by 33
HTLV-1 Infection and Rheumatic Diseases
Umekita, K., & Okayama, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00152 · Cited by 33
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
Kannagi, M., Hasegawa, A., Takamori, A., Kinpara, S., & Utsunomiya, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00323 · Cited by 33
Honjo, T., Kobayashi, M., Begum, N. A., Kotani, A., Sabouri, S., & Nagaoka, H. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394280-7.00001-4 · Cited by 32
Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice
Zhao, T., Satou, Y., & Matsuoka, M. (2014) · Archives of Virology · doi:10.1007/s00705-014-2099-y · Cited by 35
Self-citationSézary syndrome: old enigmas, new targets
Nicolay, J. P., Felcht, M., Schledzewski, K., Goerdt, S., & Géraud, C. (2016) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12900 · Cited by 31
Adult T‐cell leukemia‐lymphoma as a viral disease: Subtypes based on viral aspects
Nosaka, K., & Matsuoka, M. (2021) · Cancer Science · doi:10.1111/cas.14869 · Cited by 31
Self-citationNakahata, S., Enríquez, D., Jahan, M. I., Sugata, K., & Satou, Y. (2023) · Biomolecules · doi:10.3390/biom13101543 · Cited by 31
Self-citation
Metadata
- Authors
- Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., Yamaguchi, T., Ono, M., Sakaguchi, S., & Matsuoka, M.
- Affiliations
- Kyoto University (JP)
- Kurume University (JP)
- The Ohio State University (US)
- Corresponding author
- Matsuoka, Masao
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-10
- Volume
- 7
- Issue
- 2
- Pages
- e1001274
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3037353
- OpenAlex
- W1966278500
- Cited by
- 319
- References
- 58
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 11 · 2023: 15 · 2022: 27 · 2021: 31 · 2020: 21 · 2019: 19 · 2018: 14 · 2017: 32 · 2016: 21 · 2015: 19 · 2014: 19 · 2013: 21 · 2012: 22
- FWCI
- 11.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
- Funders
- Naito Foundation
- Sumitomo Foundation
- Uehara Memorial Foundation
- National Institutes of Health
- Japan Society for the Promotion of Science (22390193)
- National Cancer Institute (CA077556, R01CA077556)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- HTLV-1, bZIP transcription factors, HBZ, adult T-cell leukemia/lymphoma, T-cell lymphoma, regulatory T cells, Foxp3, NFAT, systemic inflammation, CD4+ T cells, transgenic mice, HTLV-1-associated myelopathy/tropical spastic paraparesis, transcriptional regulation
- MeSH terms
- Adult, Animals, Cell Transformation, Viral, Cells, Cultured, Gene Expression Regulation, Humans, Inflammation, Mice, Inbred C57BL, Mice, Transgenic, Human T-lymphotropic virus 1, HTLV-I Infections, CD4-Positive T-Lymphocytes, Lymphoma, T-Cell, Basic-Leucine Zipper Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review